Morgan Stanley Maintains Overweight on Curtiss-Wright (CW) Feb 13, 2026

Morgan Stanley maintained an Overweight rating on Curtiss-Wright Corporation (CW) on February 13, 2026. The CW analyst rating stayed positive as Morgan Stanley raised its price target to $760 from $660. Morgan Stanley cited stronger defense backlog and margin improvement as reasons for the move. This note is the only analyst action tracked on Feb 13, 2026 and it links a higher target to expected 2026 EPS growth.

Quick summary of the Morgan Stanley action and the CW analyst rating

On February 13, 2026, Morgan Stanley maintained Overweight on Curtiss-Wright and raised its price target to $760 from $660. This is a maintained positive rating rather than an upgrade or downgrade, and it signals confidence without shifting the firm’s view of relative risk.

Analyst rationale, price target details, and cited drivers for the CW analyst rating

Morgan Stanley pointed to a stronger defense backlog, margin recovery, and management guidance as reasons for lifting the CW price target to $760. The firm kept its Overweight stance while increasing upside, which implies improved earnings visibility for 2026.

You can read the Morgan Stanley note summary on TheFly and MarketWatch for the public writeups. TheFly and MarketWatch.

How the CW analyst rating change linked to stock reaction

After the Morgan Stanley note, Curtiss-Wright showed a price change since of -0.86% ($-5.94) on the reporting day. The maintained Overweight with a higher target often causes mixed near-term moves as investors weigh valuation against fundamentals.

Given the single major firm action on Feb 13, 2026, short-term volatility is normal. Longer-term moves should track earnings execution and defense order flow.

What the maintained Overweight means for investors and implications

A maintained Overweight is not a downgrade; it means Morgan Stanley still favors CW relative to peers. Investors should view the CW analyst rating as a vote of confidence in growth and margins, not a guarantee of immediate gains.

Investors seeking lower volatility may wait for execution of 2026 guidance. Active investors can weigh the new $760 target against current market price and their risk profile.

Historical analyst coverage and how this fits Curtiss-Wright’s trend

Historically, Curtiss-Wright has seen multiple analyst holds and buys tied to defense spending and industrial cycles. Morgan Stanley’s maintained Overweight in February 2026 continues a pattern of positive coverage after strong Q4 2025 results.

Market notes since the earnings release show analysts focusing on 11%–15% EPS growth guidance for 2026. That context explains why a price target increase accompanies a maintained rating.

Meyka assessment, market cap context, and what we track next

Meyka AI rates CW with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Curtiss-Wright’s market cap is $25,782,754,576. As an AI-powered market analysis platform, Meyka monitors analyst moves, guidance execution, and order backlog. Watch for follow-up notes and quarterly execution to validate the higher target.

Final Thoughts

Morgan Stanley’s action on February 13, 2026 kept Curtiss-Wright at Overweight while raising the price target to $760. The CW analyst rating therefore remains bullish but not upgraded, and Morgan Stanley expects stronger 2026 earnings and margin improvement. For investors this means the stock carries analyst support, a higher upside reference point, and reliance on execution to meet that target. Our view is that the maintained Overweight reduces immediate downside risk versus peers, but investors should track order backlog, EPS guidance execution, and subsequent analyst notes. Meyka AI rates CW with a grade of B+ to reflect relative strength, growth expectations, and consensus sentiment. These grades are not guarantees and we are not financial advisors. See CW on Meyka for ongoing coverage and model updates.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.